Associate Director, MSAT – Analytical Sciences, Biologics

Vaga não está no LinkedIn

🕒 Junho 29

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $169.222 - $253.000 / ano

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🗣️🇺🇸🇬🇧 Inglês obrigatório

Candidatar-se
Encontrar Vagas Remotas Similares

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Logo of Otsuka Pharmaceutical Companies (U.S.)

Otsuka Pharmaceutical Companies (U.S.)

1001 - 5000 funcionários

💊 Farmacêutico

🏥 Saúde

🧬 Biotecnologia

Pharmaceuticals • Healthcare • Biotechnology

As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.

Descrição

• Lead the analytical sciences function within MSAT to ensure robust support for commercial manufacturing of biologics (e.g., mAbs, fusion proteins) • Drive analytical control strategy, specification setting, and lifecycle management in alignment with QbD principles • Oversee method performance monitoring and trending, analytical capability assessments, and continuous improvement initiatives • Provide analytical subject matter expertise (SME) during technology transfers to external manufacturing sites • Support manufacturing investigations by leading root‑cause analyses, interpreting analytical data, and defining corrective and preventive actions • Guide method troubleshooting, resolution of OOS/OOT trends, and process–product linkages (CQA–CPP relationships) • Lead analytical method qualification/validation strategy to meet Phase‑appropriate and commercial requirements • Author, review, and approve analytical sections of regulatory filings (BLA/MAA, responses to agency queries) • Partner with QA, Regulatory, and MSAT to ensure compliance with global regulatory guidelines (ICH Q2, Q6B, Q14, etc.) • Partner closely with Process Development, Quality Control, Quality Assurance, Regulatory teams • Drive analytical readiness for tech transfers, PPQ readiness, comparability assessments, and lifecycle changes • Lead external oversight of CDMOs/CROs, ensuring analytical deliverables, timelines, and quality expectations are met • Ensure data integrity and proper scientific documentation across MSAT analytical activities

🎯 Requisitos

• PhD or MS in Analytical Chemistry, Biochemistry, Molecular Biology, Chemical Engineering, or related field • 8 + years (PhD) or 12+ years (MS) of experience in analytical development, QC, or MSAT for biologics • Demonstrated technical expertise in analytical methods for biologics (e.g., HPLC/UPLC, CE, LC‑MS, bioassays, ELISA, spectroscopy) • Strong experience in commercial biologics manufacturing support, tech transfer, and method lifecycle management • Deep knowledge of global regulatory expectations for biologics (ICH Q5, Q6, Q8, Q14; FDA and EMA guidance’s) • Proven leadership skills and experience managing teams or cross‑functional technical groups • Experience with commercial biologics PPQ and BLA/MAA submissions • Expertise in statistical tools (e.g., JMP, Minitab) and digital data systems (e.g., LIMS) • Experience working with CDMOs/CROs and external manufacturing partners • Strong understanding of CQAs, control strategy development, and analytical–process integration.

🏖️ Benefícios

• Comprehensive medical, dental, vision, prescription drug coverage • Company provided basic life, accidental death & dismemberment, short-term and long-term disability insurance • Tuition reimbursement • Student loan assistance • A generous 401(k) match • Flexible time off • Paid holidays • Paid leave programs • Other company provided benefits

Candidatar-se

Vagas Similares

🕒 Junho 29

Jones Lang LaSalle Americas, Inc.

10.000+ funcionários

🏠 Imobiliário

🤝 B2B

💼 Consultoria

Global Transaction Management Leader overseeing real estate strategy and execution. Leading complex transactions and developing solutions for office, manufacturing, and flex spaces.

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $140.000 - $160.000 / ano

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🗣️🇺🇸🇬🇧 Inglês obrigatório

🕒 Junho 29

Jazz Pharmaceuticals

1001 - 5000

🏥 Saúde

🏭 Manufatura

🧬 Biotecnologia

Lead scientific team for oncology pharmacology in a global biopharma organization. Focused on developing innovative oncology therapies at Jazz Pharmaceuticals.

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $232.000 - $348.000 / ano

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🦅 Patrocina Visto H1B

info

🗣️🇺🇸🇬🇧 Inglês obrigatório

🕒 Junho 29

Come and See Foundation

11 - 50

🤝 Sem Fins Lucrativos

🤲 Filantropia

📱 Mídia

Senior International Development Director cultivating major-gift supporters to generate $5M+ annually for Come and See. Building long-term partnerships across diverse international regions.

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $165.000 - $180.000 / ano

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🗣️🇺🇸🇬🇧 Inglês obrigatório

🕒 Junho 27

Eli Lilly and Company

10.000+ funcionários

💊 Farmacêutico

🏥 Saúde

🧬 Biotecnologia

Senior Director in Commercial Insights & BD Forecasting leading market assessments and forecasting. Driving BD analytics quality and supporting partnership opportunities in pharmaceutical markets.

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $169.500 - $275.000 / ano

💰 $6.500.000 Post-IPO Debt - Eli Lilly em 2024-02

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🗣️🇺🇸🇬🇧 Inglês obrigatório

🕒 Junho 27

QIAGEN

5001 - 10000

🧬 Biotecnologia

🏥 Saúde

Health Systems Executive at QIAGEN responsible for managing enterprise accounts and driving revenue growth across healthcare IDNs. Collaborating with various internal teams and strategic partners while focusing on long-term partnerships.

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $130.000 - $170.000 / ano

🔥 Investimento no último ano

💰 $750.000.000 Post-IPO Debt - Qiagen em 2025-08

⏰ Tempo Integral

🟠 Sênior

👔 Diretor

🗣️🇺🇸🇬🇧 Inglês obrigatório